NanoString Technologies is a leading provider of life science tools for translational research. The company’s nCounter® Analysis System is used in life sciences research and has been cited in more than 3,200 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company’s GeoMx™ Digital Spatial Profiler enables highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections. For more information, please visit www.nanostring.com.
New technologies are enabling discoveries that advance our understanding of how tumors develop, evade the immune system, and progress. This virtual conference brings together research professionals, scientists, and clinicians from around the world to learn and discuss recent advances in cancer research with a focus on biomarker discovery, immuno-oncology and clinical applications across all cancer types.
Plenary Sessions:
Scientific tracks:
This free online event allows you to participate in a global setting with no travel or cost to you. The event will remain open for twelve months from the date of the live event.
Director, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy
Director of the Center for Cellular Immunotherapies, Perelman School of Medicine and Director of the Parker Institute for Cancer Immunotherapy, University of Pennsylvania
Chief Medical Officer, ESSA Pharmaceuticals
Head Medical Oncology Department, Hospital Clinic of Barcelona, Head Translational Genomics & Targeted Therapeutics in Solid Tumors Group, Hospital Clinic of Barcelona
Director of Research & Development, Celyad
Associate Professor of Medicine at UNSW Sydney, NHMRC Senior Research Fellow and co-head of the Breast Translational Oncology Program in the Kinghorn Cancer Center, Sydney
Research Scientist, Parker Institute for Cancer Immunotherapy
Associate Product Manager, NanoString Technologies
Director of Clinical Development and Research at MacroGenics, Inc.
Application Scientist - Advanced Cell Diagnostics
Senior Product Manager, NanoString Technologies
Clinical Fellow in Radiation Oncology, Massachusetts General Hospital, Radiation Oncology
Peter Doherty NHMRC Early Career Fellow at the Queensland University of Technology (QUT)
Assistant Professor, Group Leader of the Tumor Immuno-Pathology (TIP) Laboratory, Erasmus University Medical Center
Professor of Medicine at the University of Washington
Senior Bioinformatics Scientist, NanoString Technologies
Thoracic Oncology Consultant, Hospital Clínic de Barcelona
Professor of Cancer Immunotherapy, John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University
Professor i Kirurgi, Lund University, Medical Faculty, dept of Clinical Sciences Lund, div of Oncology and Surgery
Principal Research Scientist at Ontario Institute for Cancer Research
Professor of Cancer Biology, Mayo Clinic Comprehensive Cancer Center
Physician Scientist, Department of Medical Oncology, Lung Cancer Unit
Bio-Techne empowers researchers in Life Sciences and Clinical Diagnostics by providing high-quality reagents, instruments, custom manufacturing, and testing services. Our family of brands creates a unique portfolio of products and services. Science is our passion; it drives us ...
See moreLeica Biosystems is a global leader in Anatomical Pathology solutions and automation, striving to advance cancer diagnostics to improve patients' lives. Leica Biosystems provides Pathologists, Histologists, and Researchers a comprehensive range of products for each step in the ...
See moreBased in the Genomics Capital of San Diego, OnRamp BioInformatics provides ROSALIND™, the first-ever genomics analysis platform specifically designed for life science researchers to analyze and interpret datasets, without any prior bioinformatics skills.